When cancer patients undergo chemotherapy, they often face a common and distressing side effect: neuropathic pain. This pain can be so severe that some patients have to discontinue their cancer treatment.
However, there is new hope on the horizon. Researchers, led by Oncode Investigator Mario van der Stelt and his team, have found a potential new drug that can help relieve this pain.
Neuropathic pain is a type of pain caused by damage or dysfunction of the nerves. It can feel like burning, tingling, or electric shocks and is often difficult to treat. For cancer patients, this pain can be a significant challenge, and finding effective medications to manage it is crucial.
The newly discovered drug, called LEI-515, works by preventing the breakdown of a natural compound in our bodies.
This compound is similar to a component found in marijuana and is known as 2-arachidonoylglycerol. By stopping the breakdown of this compound, LEI-515 can help reduce neuropathic pain.
In their study, the researchers tested LEI-515 in a mouse model. They found that the drug was effective in reducing neuropathic pain caused by a chemotherapy drug called paclitaxel.
What’s even more promising is that LEI-515 does not have the psychoactive effects (behavioral changes) often associated with medications like marijuana, and it does not lead to physical dependence in mice.
This discovery opens the door to the development of new pain-relief drugs, known as analgesics, for cancer patients. These drugs could potentially offer relief from neuropathic pain without the side effects associated with other medications.
Mirjam Huizenga, the first author of the research paper, highlighted the importance of this discovery for cancer patients.
She said, “Cancer patients who suffer from chemotherapy-induced neuropathic pain are in dire need of effective medication without side effects, and our study provides promising results toward that goal.”
The journey to finding new treatments for neuropathic pain is a critical one. Cancer patients often face numerous challenges during their treatment journey, and managing pain is a top priority.
While this research is a significant step forward, further studies and clinical trials will be needed to determine the drug’s safety and effectiveness in humans.
Neuropathic pain is just one of the many challenges that cancer patients and their healthcare teams face. Finding ways to improve the quality of life for these patients is at the heart of ongoing research efforts.
With continued dedication and scientific exploration, we can hope for more breakthroughs that will make the cancer journey a little less painful for those who are fighting this disease.
The research findings can be found in Nature Communications.
Copyright © 2023 Knowridge Science Report. All rights reserved.
